JP2018526352A5 - - Google Patents

Download PDF

Info

Publication number
JP2018526352A5
JP2018526352A5 JP2018506301A JP2018506301A JP2018526352A5 JP 2018526352 A5 JP2018526352 A5 JP 2018526352A5 JP 2018506301 A JP2018506301 A JP 2018506301A JP 2018506301 A JP2018506301 A JP 2018506301A JP 2018526352 A5 JP2018526352 A5 JP 2018526352A5
Authority
JP
Japan
Prior art keywords
group
alkyl
substituted
optionally
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018506301A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018526352A (ja
JP6816107B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/068291 external-priority patent/WO2017025368A1/en
Publication of JP2018526352A publication Critical patent/JP2018526352A/ja
Publication of JP2018526352A5 publication Critical patent/JP2018526352A5/ja
Application granted granted Critical
Publication of JP6816107B2 publication Critical patent/JP6816107B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018506301A 2015-08-07 2016-08-01 インダニルアミノピリジルシクロプロパンカルボン酸、医薬組成物及びこれらの使用 Expired - Fee Related JP6816107B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP15180175 2015-08-07
EP15180175.0 2015-08-07
EP15199739 2015-12-14
EP15199739.2 2015-12-14
PCT/EP2016/068291 WO2017025368A1 (en) 2015-08-07 2016-08-01 Indanylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof

Publications (3)

Publication Number Publication Date
JP2018526352A JP2018526352A (ja) 2018-09-13
JP2018526352A5 true JP2018526352A5 (cg-RX-API-DMAC7.html) 2020-11-05
JP6816107B2 JP6816107B2 (ja) 2021-01-20

Family

ID=56618142

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018506301A Expired - Fee Related JP6816107B2 (ja) 2015-08-07 2016-08-01 インダニルアミノピリジルシクロプロパンカルボン酸、医薬組成物及びこれらの使用

Country Status (4)

Country Link
US (1) US9617251B2 (cg-RX-API-DMAC7.html)
EP (1) EP3331860B1 (cg-RX-API-DMAC7.html)
JP (1) JP6816107B2 (cg-RX-API-DMAC7.html)
WO (1) WO2017025368A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10125101B2 (en) 2016-11-28 2018-11-13 Boehringer Ingelheim International Gmbh Indanylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
CN110214135B (zh) * 2017-01-26 2023-02-21 勃林格殷格翰国际有限公司 茚满基氨基吡嗪基环丙烷羧酸、药物组合物及其用途
JOP20180040A1 (ar) * 2017-04-20 2019-01-30 Gilead Sciences Inc مثبطات pd-1/pd-l1
CN118084940A (zh) 2018-02-13 2024-05-28 吉利德科学公司 Pd-1/pd-l1抑制剂
MA51232A (fr) 2018-02-22 2020-10-07 Chemocentryx Inc Indane-amines utiles en tant qu'antagonistes de pd-l1
US12083118B2 (en) 2018-03-29 2024-09-10 Arbutus Biopharma Corporation Substituted 1,1′-biphenyl compounds, analogues thereof, and methods using same
AU2019255750B2 (en) 2018-04-19 2021-10-21 Gilead Sciences, Inc. PD-1/PD-L1 inhibitors
PE20210642A1 (es) 2018-07-13 2021-03-23 Gilead Sciences Inc Inhibidores de pd-1/pd-l1
EP3865477B1 (en) * 2018-10-10 2023-07-12 Korea Research Institute of Bioscience and Biotechnology Carbene compound, carbene-metal nanoparticle complex and preparation method thereof
CN112955435B (zh) 2018-10-24 2024-09-06 吉利德科学公司 Pd-1/pd-l1抑制剂
IL291985A (en) 2019-10-07 2022-06-01 Kallyope Inc Gpr119 agonists
PH12022552277A1 (en) 2020-02-28 2024-03-04 Kallyope Inc Gpr40 agonists
UY39222A (es) 2020-05-19 2021-11-30 Kallyope Inc Activadores de la ampk
EP4172162A4 (en) 2020-06-26 2024-08-07 Kallyope, Inc. AMPK ACTIVATORS

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003277576A1 (en) * 2002-11-08 2004-06-07 Takeda Pharmaceutical Company Limited Receptor function controlling agent
EP1726580A4 (en) * 2004-03-15 2008-02-13 Takeda Pharmaceutical AMINOPHNYLPROPANO ACID DERIVATIVE
EP1924546A1 (en) * 2005-09-14 2008-05-28 Amgen, Inc Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
US8633182B2 (en) * 2012-05-30 2014-01-21 Boehringer Ingelheim International Gmbh Indanyloxyphenylcyclopropanecarboxylic acids
WO2015024526A1 (en) * 2013-08-23 2015-02-26 Fujian Haixi Pharmaceuticals Co., Ltd Carboxylic acid compounds in treatment of diabetes mellitus

Similar Documents

Publication Publication Date Title
JP2018526352A5 (cg-RX-API-DMAC7.html)
JP2018526405A5 (cg-RX-API-DMAC7.html)
JP2020505393A5 (cg-RX-API-DMAC7.html)
JP2020505400A5 (cg-RX-API-DMAC7.html)
JP2019535792A5 (cg-RX-API-DMAC7.html)
JP2020505394A5 (cg-RX-API-DMAC7.html)
JP2020514315A5 (cg-RX-API-DMAC7.html)
JP2020506205A5 (cg-RX-API-DMAC7.html)
RU2403258C2 (ru) Тиазолилдигидроиндазолы
JP2019532110A5 (cg-RX-API-DMAC7.html)
CL2020000363A1 (es) Inhibidores macrocíclicos de mcl-1 y métodos de uso.
JP2019504050A5 (cg-RX-API-DMAC7.html)
EP4458348A3 (en) Pharmaceutical compositions containing substituted polycyclic pyridone derivatives and prodrug thereof
JP2015504081A5 (cg-RX-API-DMAC7.html)
JP2021504317A5 (cg-RX-API-DMAC7.html)
IL274229B2 (en) Antibacterial compounds
JP2017511360A5 (cg-RX-API-DMAC7.html)
HRP20120696T1 (hr) Spiro-prstenasti spoj i njegova medicinska upotreba
JP2015516427A5 (cg-RX-API-DMAC7.html)
RU2019130519A (ru) 4-пиридоновое соединение или его соль, фармацевтическая композиция и содержащий их состав
JP2016534084A5 (cg-RX-API-DMAC7.html)
MX2020014116A (es) Agente profilactico o terapeutico para atrofia muscular espinal.
RU2016134749A (ru) Гетероциклическое сульфонамидное производное и лекарственное средство, содержащее такое производное
JP2015537017A5 (cg-RX-API-DMAC7.html)
IL313466B1 (en) Inhibiting creb binding protein (cbp)